by
Loren Bonner, DOTmed News Online Editor | May 10, 2013
A bipartisan bill that would require health insurers to cover additional breast screenings if a mammogram demonstrates dense breast tissue is advancing in the New Jersey Assembly.
The bill, sponsored by two Republicans and six Democrats, would require health insurance companies to cover ultrasound, MRI, 3-D mammography (tomosynthesis) and other supplemental breast screenings when a mammogram demonstrates a woman has dense breast tissue or her doctor deems it medically necessary due to other risk factors.
"A mammogram will detect only about 48 percent of tumors in women with dense breast tissue, meaning the rest will elude early detection," said one of the bill sponsors, Troy Singleton (D-Burlington), in a statement.

Ad Statistics
Times Displayed: 109569
Times Visited: 6641 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Like other bills passed in Connecticut, Texas, Virginia, California, New York and Hawaii in recent years, the New Jersey bill would also require mammography reports to contain information on breast density so that doctors will have to speak with women about the risks.
Connecticut and Illinois are the only states that require insurance coverage for supplemental screenings, specifically ultrasound and MRI. (Though a bill has been introduced, Illinois still does not have an "inform" law that requires doctors to talk to women about the risks of their dense breast tissue.)
Studies have shown that women with dense breast tissue — which often makes it hard for radiologists to see abnormalities on a mammogram — have a higher rate of breast cancer. However, a recent study from the Journal of the National Cancer Institute found breast density was not linked to increased cancer deaths. There is also debate in the medical community about what constitutes breast density in a woman, even though imaging equipment vendors have developed special qualitative software aimed at measuring breast density.
The bill was approved by the New Jersey Assembly Appropriations Committee and now awaits consideration by the full Assembly.
Victor Levenson
Imaging - problems with approach
May 16, 2013 12:01
Imaging by definition can detect only lesions larger than a given threshold. Even with contrasting agents it still needs a certain amount of malignant (or benign!) cells to be present (current estimate according to NCI is 110 breast cancer cells). Meanwhile existing technologies allow development of a precise blood-based test that will not only detect breast cancer earlier, but will also differentiate between malignant and benign growth. Moreover, it will be useful for younger women, who will not have to go through what A Jolie just went through. The test can be ready in 18 mo but development costs are ~$0.75M. Anybody interested?
to rate and post a comment